PAIN
Volume 130, Issue 3 , Pages 299-300, August 2007

Authors’ reply to the letter to the editor by Peter Reilich and Benedikt G.H. Schoser regarding the published article entitled “Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport®) for the relief of upper back myofascial pain syndrome: Results from a randomised double-blind placebo-controlled multicentre study”, Pain 2006;125:82–8.

  • Hartmut Göbel

      Affiliations

    • Corresponding Author InformationTel.: +49 431 200 99 65; fax: +49 431 200 99 35.
    web address

Neurology and Behavioural Medicine, Kiel Neurological Pain and Headache Centre, Heikendorfer Weg 9-27, D-24149 Kiel, Germany

Received 12 April 2007; accepted 23 April 2007. published online 16 June 2007.

No abstract is available. To read the body of this article, please view the Full Text online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0304-3959(07)00216-3

doi:10.1016/j.pain.2007.04.033

Refers to article:

  • Accuracy of botulinum toxin injections in myofascial pain. Response to Gobel et al. Pain 2006;125:82–8 , 29 May 2007

    Peter Reilich, Benedikt G.H. Schoser
    PAIN August 2007 (Vol. 130, Issue 3, Page 299)

PAIN
Volume 130, Issue 3 , Pages 299-300, August 2007

Article Tools